Analytics
Consensus Analysis | SOBI | 13 August 2026
Consensus Analysis | Getinge | 11 August 2026
Novo raises outlook, BioInvent breaks through, Nordics tread water – the Nordic Pulse | 2026:32
Consensus Analysis | Astra Zeneca | 6 August 2026
Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31
Novo sues Lilly, Alligator collapses, Lundbeck completes Phase III – the Nordic Pulse | 2026:30
Leqembi under the skin, Wegovy wins Europe, Sobi lifts guidance – the Nordic Pulse | 2026:29
AstraZeneca drags the index, Ascelia contests the FDA and board drama at BICO – the Nordic Pulse | 2026:28
BioVal™ analysis: Alzinova’ ALZ-101 valued at SEK 7.1B
BioVal
Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27
Analytics
State of Nordic Biopharma | Q2 2026
Analytics
BioVal™ analysis: Elicera Therapeutics’ ELC-301 valued at SEK 631M
BioVal
Krönikor
Gästkrönika: Europa har inte råd att stå still när omvärlden accelererar
Oseriöst när PharmaLundensis hävdar att aktien är värd 3 kronor
USA borde städa framför egen dörr innan de pekar finger
BIOVAL
Du är värd det bästa!
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
Rekommenderat
Årets stora kursraketer inom nordisk life science
AlzeCures vd om sommarens andra miljardavtal
SynAct Pharma: ’Best BIO ever”
Kommande event!
Investing in Life Science
Set in vibrant Stockholm, the finance capital of Sweden, this boutique investor event connects regional life science leaders looking for...
Life Science Summit 2026
BioStock is delighted to welcome you to the 9th annual BioStock Summit, the premier event bringing the Nordic life science...
MedTech Summit 2027
After a phenomenal debut last year, the premier gathering for medical technology is officially back. The response to our inaugural...
